| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970578 | The Journal of Heart and Lung Transplantation | 2013 | 9 Pages |
Abstract
Our study confirms that the use of ECMO as a bridge to LTx in France could provide a medium-term survival benefit for LTx recipients with critical conditions. Survival differed by underlying respiratory disease. Larger studies are needed to further define the optimal use of ECMO.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marion MD, Pierre MD, Gabriel MD, PhD, Laurent MD, Pierre-Emmanuel MD, Alain MD, Françoise MD, PhD, Jean-Michel MD, Martine MD, PhD, Christelle MD, Edouard MD, Marc MD, Pascal MD, PhD, Yves MD, PhD, Richard MD, Hervé MD, PhD,